-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Structure Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2022 to 2024.
- Structure Therapeutics Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$47.1M, a 51.8% decline year-over-year.
- Structure Therapeutics Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$158M, a 54% decline year-over-year.
- Structure Therapeutics Inc. annual Operating Income (Loss) for 2024 was -$158M, a 54% decline from 2023.
- Structure Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$103M, a 95.5% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)